Smith & Nephew plc (SN) Receives Average Rating of “Hold” from Brokerages
Smith & Nephew plc (LON:SN) has been given an average recommendation of “Hold” by the twelve brokerages that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is GBX 1,300.55 ($17.16).
Several research analysts recently weighed in on the company. Deutsche Bank AG upped their price target on Smith & Nephew plc from GBX 1,200 ($15.84) to GBX 1,315 ($17.35) and gave the company a “hold” rating in a research report on Monday, October 23rd. J P Morgan Chase & Co upped their price target on Smith & Nephew plc from GBX 1,361 ($17.96) to GBX 1,382 ($18.24) and gave the company a “neutral” rating in a research report on Thursday, October 19th. Citigroup Inc. reissued a “sell” rating and set a GBX 1,160 ($15.31) price target on shares of Smith & Nephew plc in a research report on Friday, October 6th. Credit Suisse Group reissued a “neutral” rating and set a GBX 1,200 ($15.84) price target on shares of Smith & Nephew plc in a research report on Thursday, July 20th. Finally, Jefferies Group LLC upped their price target on Smith & Nephew plc from GBX 1,350 ($17.81) to GBX 1,515 ($19.99) and gave the company a “buy” rating in a research report on Friday, July 28th.
COPYRIGHT VIOLATION NOTICE: This report was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/10/29/smith-nephew-plc-sn-receives-average-rating-of-hold-from-brokerages-2.html.
Shares of Smith & Nephew plc (SN) opened at 1428.00 on Friday. Smith & Nephew plc has a 52-week low of GBX 1,064.91 and a 52-week high of GBX 1,442.00. The stock’s market cap is GBX 12.50 billion. The company’s 50-day moving average price is GBX 1,378.08 and its 200-day moving average price is GBX 1,341.74.
In related news, insider Virginia Bottomley purchased 223 shares of the firm’s stock in a transaction dated Wednesday, August 16th. The stock was bought at an average price of GBX 1,380 ($18.21) per share, for a total transaction of £3,077.40 ($4,060.97).
About Smith & Nephew plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.